Who has invested in Cytospire Therapeutics?

Abingworth are named among the investors backing Cytospire Therapeutics.

Cytospire Therapeutics Funding: $83M Raised, Series A (2026)

Cytospire Therapeutics funding overview

Cytospire Therapeutics has raised $83M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2026. The round record for Cytospire Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Abingworth.

Cytospire Therapeutics at a glance

Total raised: $83M
Latest round: Series A
Latest round date: May 2026
Notable investors: Abingworth

Frequently asked about Cytospire Therapeutics funding

How much has Cytospire Therapeutics raised?: Cytospire Therapeutics has raised $83M in total disclosed funding across the rounds on record.
Who has invested in Cytospire Therapeutics?: Abingworth are named among the investors backing Cytospire Therapeutics.
What was the latest Cytospire Therapeutics funding round?: The most recent disclosed round is a Series A, announced in May 2026.
Where is Cytospire Therapeutics based?: No headquarters location is disclosed for Cytospire Therapeutics.
When did Cytospire Therapeutics last raise?: The last disclosed Cytospire Therapeutics round closed in May 2026 at Series A.

Round data for Cytospire Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Cytospire Therapeutics Funding: $83M Raised, Series A (2026)

Cytospire Therapeutics funding overview

Cytospire Therapeutics at a glance

Frequently asked about Cytospire Therapeutics funding

Companies related to Cytospire Therapeutics (18)

Browse related funding lists (4)